Episode description
Tyler Rodewald, VP, M&A at EIS Holdings
In a world where change is the only constant, businesses are continually seeking innovative ways to stay ahead of the curve. One such method that has gained prominence is the corporate diversification strategy, a multifaceted approach that can lead to new growth avenues and enhanced resilience.
In this episode of the M&A Science Podcast, Tyler Rodewald, VP, M&A at EIS Holdings, discusses corporate diversification through M&A.
Things you will learn:
• Corporate diversification strategy
• Drivers of corporate diversification
• People involved in corporate diversification
• Projecting revenue synergies
• Closing deals with competition
This episode is brought to you by the M&A Science Spring Summit 2024 happening on April 10th at 10AM ET. It's your chance to join leading M&A experts as they share innovative and the latest trends from their own deals. Save your spot here.
******************
Episode Bookmarks
00:00 Intro
02:55 Corporate diversification strategy
03:32 Drivers of corporate diversification
05:22 People involved in corporate diversification
08:00 Communicating the diversification strategy - The number one step
08:51 Customer overlaps on deals
11:17 Capital Allocation
13:41 Proprietary deal vs Bank Deal
15:22 Deal Sourcing
17:57 Closing deals with competition
19:22 Cultural integration
22:03 Handling resistance
23:21 Measuring Success
24:31 Projecting revenue synergies
26:09 Earnouts
30:31 Letter on intent exclusivity
32:10 Combining diligence with integration using DealRoom
36:42 Using DealRoom with Sellers
40:02 Advice for practitioners doing corporate diversification
40:30 AI in M&A
46:34 Craziest thing in M&A